EODData

NASDAQ, CADL: Candel Therapeutics Inc

09 Dec 25 18:16
LAST:

5.660

CHANGE:
 0.21
OPEN:
5.470
HIGH:
5.780
ASK:
0.000
VOLUME:
784.2K
CHG(%):
3.85
PREV:
5.450
LOW:
5.385
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Dec 255.4705.7805.3855.660784.2K
08 Dec 255.4205.6505.4035.450889.2K
05 Dec 255.2105.4305.1905.330983.4K
04 Dec 255.0005.3204.9705.2601.38M
03 Dec 254.4505.0504.4255.0201.21M
02 Dec 254.5204.5404.3804.420559.9K
01 Dec 254.6704.7054.4204.480817.5K
28 Nov 254.6604.8704.6304.770478.0K
26 Nov 254.4804.6604.4204.620969.9K
25 Nov 254.5704.5704.3504.470652.8K

PROFILE

Name:Candel Therapeutics Inc
About:Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:117 Kendrick Street, Needham, MA, United States, 02494
Website:https://www.candeltx.com
CUSIP:137404109
CIK:0001841387
ISIN:US1374041093
FIGI:BBG00N0D4Z71

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-3.00 
Forward P/E:-5.91 
PEG Ratio:0.03 
Price to Sales:436.42 
Price to Book:3.27 
Return on Assets:-0.33 
Return on Equity:-0.55 
EPS Ratio:-0.66 
Revenue:31.0K 
Shares:54.9M 
Market Cap:310.71M 

TECHNICAL INDICATORS

MA5:5.345.9%
MA10:4.9514.4%
MA20:4.8018.0%
MA50:5.238.2%
MA100:5.502.9%
MA200:5.700.7%
STO9:91.18 
STO14:91.18 
RSI14:72.61 
MTM14:1.24
ROC14:0.28 
ATR:0.30 
Week High:5.782.1%
Week Low:4.3829.2%
Month High:5.782.1%
Month Low:4.350.7%
Year High:14.60158.0%
Year Low:4.2533.2%